Introduction
At the dawn of transplantation in 1954, a future in which this therapy would be appropriate for recipients in their retirement years and in which organs would be donated by people in that same phase of life was not imaginable [1] . Yet, such is our reality more than half a century after the first successful transplantation was performed between 23-year-old identical twin brothers. Renal transplantation is now so predictably successful, even for persons in their eighth decades who have a 2-year survival rate of 80%, that many of the elderly people confronting end-stage renal disease (ESRD) fully expect to be offered this therapy, often feeling entitled to it [2] . For their nephrologists, who have by necessity become geriatricians [3] , annual consideration of transplantation in the management plan of each patient, regardless of age, has become a regulatory requirement because of the long-term cost advantage of successful transplantation compared to maintenance dialysis [4] . But for these elderly candidates, as for any category of patients, simple proof of the principle that transplantation can be successfully accomplished, does not assure its routine delivery to all. The associated reality that patients do not live in a vacuum, and must compete with all others for healthcare resources must be addressed. Thus, geriatric candidates join the thousands of pediatric [5] , diabetic [6] , obese [7] , human immunode-c15 ficiency virus-infected [8] , and many other types of ESRD patients, all candidates whose survival expectations are longer with transplantation than on dial ysis.
Without parallel growth in the availability of organ donors during these past 50 years, the rate-limiting step in providing transplants for all who might benefit has definitively become the supply of organs. For society as a whole, the determination of which of the myriad qualified patients should be allocated scarce organs is contentious and painful -an unwinnable battle. To be fair, a patient selection system must be based on preestablished rules applied in a transparent manner. Patients must be capable of comprehending the allocation policies and of making informed choices to promote their own access to organs. So, for the elderly, as for patients of all ages, to compete effectively for access to transplantation, it is of vital importance that comprehensive ESRD education including all aspects of transplantation be imparted and absorbed. Such patient advocacy must incorporate consideration of all legitimate strategies for optimization of the system of deceased-donor allocation. Informed participation in making the key decisions that will determine whether or not transplantation ensues has become the standard of care.
Which Patient?
Renal transplantation does not specifically ameliorate, and may even aggravate comorbid conditions in the ESRD patient, particularly those degenerative diseases that increase in frequency with aging. For this reason, pretransplantation selection criteria ( table 1 ) focus on realistic assessment of the extent and prognosis of the candidate's other diseases, such as heart disease and malignancy. Those anticipated to limit the patient's ability to benefit from a technically successful transplantation over a sufficient time frame to justify the resource utilization (this includes finances as well as the organ itself), such as advanced small vessel coronary artery disease [9] , become contraindications to transplantation. Others, such as quiescent inflammatory bowel disease, do not. These determinations often require an expert assessment of available medical evidence combined with judgment that is to some degree, subjective. Two prostate diseases nicely illustrate these issues.
Benign prostatic hyperplasia (BPH) incidence increases with age to reach a maximum prevalence of 90% of men age 1 80 years [10] . Its presence in men with ESRD and minimal urine production has only minimal clinical relevance because of the absence of associated symptoms, unless transplantation is desired. Once these men undergo technically successful transplantation and restoration of urine production, voiding dysfunction may newly become sufficiently significant to require the use of a medication or an invasive procedure for management. Tsaur et al. [11] did find a 27% incidence of posttransplantation voiding dysfunction in newly transplanted men aged 60 years and older; BPH was the cause in 93% of these patients, of whom 81% required surgical resection at a mean of 31 days after transplant. On the other hand, identification of clinically relevant BPH through objective testing is notoriously challenging, particularly in ESRD. If diagnosed, BPH might lead to inappropriate operations in some men who are subsequently transplanted without becoming symptomatic, or conversely, to unnecessary preemptive prostate operations for men who die without receiving transplants.
Prostate cancer will affect 16% of men born today [12] , increases in frequency with aging and is the second helpful example of a pretransplantation dilemma. Although it is the second leading cause of cancer-related death among US males [13] , three quarters of all newly diagnosed prostate cancers are clinically localized (stage I or stage II) and associated with a nearly 100% cancer-related survival [14] . When compared to the 5-year survival rate of only 35% for all US patients on dialysis [15] , it is apparent that kidney failure, not early prostate cancer, is most likely to limit life expectancy. Thus, the specific questions ( table 3 ) .
While the medical conditions and diseases identified in an elderly kidney transplantation candidate can be evaluated through algorithms similar to those outlined above, patients may still be considered unsuitable candidates despite having met a transplantation team's selection criteria for each of the comorbidities. Comprehensive assessment of the person's ability to survive and thrive with transplantation is much more than simple summation of each of these risks, particularly for the elderly patient. This judgment really represents the team's collective subjective opinion of the likelihood of sufficiently improving the patient's survival and quality of life over an admittedly vague, but protracted horizon to warrant the investment of the requisite resources. The patient's activity level and exercise capacity are the best objective measures of this overall recovery potential identified thus far. Those individuals incapable of performing their own activities of daily living (grooming, preparing meals and food shopping) and light exercise, such as walking at least 3 or more times per week, are at significantly increased risk of graft loss and mortality at 1 and 3 years [16] . It is neither reasonable nor realistic to offer transplantation to an inactive, uninvolved old person for whom reengagement in life represents excessive optimism. Transplantation should not be considered an acceptable exercise in futility if the ability to offer this life-saving therapy to other patients is adversely affected by doing so.
Which Kidney(s)?
An ideal renal transplantation world would contain sufficient deceased-donor organs for all appropriate candidates, and an absence of need for live-donor kidneys. Unfortunately, the real world has such a dramatic and enlarging gap between available organs and suitable candidates that death is a statistical likelihood for approximately 5% per year of those ESRD patients on the waiting list (4,638 patients on the US kidney wait-list died in 2008 [17] ). For the elderly ESRD patient who does not want to die on dialysis, and whose projected survival is already limited, the stakes are high. As for all candidates, transplant outcomes are best with a live-donor kidney. In practice, however, many elderly candidates are understandably reluctant to consider subjecting a relative or acquaintance who is substantially younger than they are (young live donor = YLD) to the risks of a donor nephrectomy. Increasing experience with the use of older living donors (old live donor = OLD) includes 3-year patient survival rates of 88% from live donors older than 55 years [18] . Although a lower percentage of older donors will meet donation criteria, such older kidneys are still superior to all deceased-donor kidneys. These success rates should be What is the life expectancy with treatment for prostate cancer and subsequent kidney transplantation, as opposed to the risk of dying on dialysis with or without treatment for prostate cancer?
What is the best treatment option if the tumor is clinically confined to the prostate?
Can preoperative nomogram calculation accuracy be improved after the patient undergoes a radical prostatectomy, so that he can face the kidney transplantation with a more certain progression-free probability prediction?
How does immunosuppression affect the probability of prostate cancer recurrence? Today's US computer-generated wait-list includes a separate field for classification of the deceased-donor kidneys as standard-criteria donor (SCD) or expandedcriteria donor (ECD), based on the age, cause of death, history of hypertension and serum creatinine of the donor. Although there is some overlap between categories, outcomes in both the short-and long-term horizons are better with SCD kidneys than with ECD kidneys, even in recipients above 59 years of age. Organ Procurement and Transplantation Network data, for example, show 3-year graft survival rates of 65, 77, 83 and 86% for ECD, SCD, OLD and YLD kidneys, respectively; 3-year patient survival rates trend similarly and are 74, 82, 88 and 89% for ECD, SCD, OLD and YLD recipients, respectively [19] . Since the mean waiting time for an ECD kidney is generally shorter than for an SCD kidney, those patients willing to accept an ECD kidney are transplanted more frequently, with 27% eventually undergoing transplantation versus 21% of those unwilling [19] . Similarly, there is a significantly decreased relative risk of death for those elderly waiting candidates who are ECD willing (hazard ration of 0.89, p ! 0.001), versus the ECD unwilling.
The final strategy for facilitating renal transplantation in the elderly is the use of two ECD deceased-donor kidneys that are declined for use as single organs due to poor function. Irrespective of the specific technical approach (bilateral retroperitoneal approaches vs. unilateral retroperitoneal approach vs. intraperitoneal approach), a larger and more complex operation demands more from the recuperating patient, and might be too extensive for some elderly patients. For example, D'Arcy et al. [20] reported that 8% of 24 dual-kidney recipients died in the postoperative period, versus 0% of 44 single-organ recipients. However, reports of good outcomes such as 1-and 5-year graft survival of 86 and 69% [21] from transplantations that would otherwise not have taken place, suggest that this strategy continues to enhance patient access to transplantation.
Immunosuppression
Successful kidney transplantation depends on pharmacologic suppression of the immune system without causing excessive side effects such as opportunistic infection or malignancy that may threaten the host's survival. Fortunately, preventing rejection of the transplanted kidney is generally easier to accomplish in older patients than younger ones, particularly those with associated chronic illness contributing to naturally occurring senescence of the immune system. Thymic involution [22] , impaired T cell proliferation and cytokine production [23] , decreased interleukin-2 production, decreased effector T cell and natural killer cell response [24] are some of the specific changes in immunity in the elderly [25] that prove to be beneficial. In clinical practice, the impaired condition of their helper T cells (CD4+) renders transplant recipients less responsive to the allogeneic kidney graft in patients 1 60 years of age [26] . Dose reduction of immunosuppressive drugs is associated with improved graft and patient survival [27] . With lower doses, cost and side effects are both reduced with a favorable impact on overall healing, bone and muscle strength, all of which may further limit the elderly patient's ability to optimize mobility and activity level.
Psychosocial Issues for the Geriatric Renal-Transplantation Candidate
To attain the long-term objectives of prolonged survival and improved quality of life, transplantation depends on partnership with the patient and her (his) support system for medication administration, adherence to visits with health care providers, and pursuit of standard health maintenance activities, such as intellectual stimulation, exercise and ingestion of a nutritionally sound diet ( table 4 ) . For geriatric patients who are at increased risk of dementia, poor eyesight, depression, social isolation through death and illness of relatives and contemporaries, irreversible physical deterioration and financial limitation, compliance with these expectations may be particularly challenging. Even when home nursing is arranged for newly discharged patients taking three or more medications, pill counts demonstrate underadher- ence ( ! 70% adherence), and overadherence ( 1 120% adherence) with at least one medication in 31 and 18%, respectively, of patients [28] . Interventions such as regular telephone reminders or videotelephone supervision, shown to improve medication compliance when compared to control groups of patients over the age of 65 years whose adherence drops from 81 to 57% [29] , may be useful assets in achieving successful transplantation in geriatric patients.
Conclusions
The geriatric ESRD patient who desires to preserve a high quality and prolonged life should pursue kidney transplantation with full knowledge of the increased risks, differential quality of specific organ types and expectations for her (his) own participation in the comprehensive transplantation regimen of medications, visits to providers, physical activity and dietary prudence. For the most robust, viable candidates, transplantation of any kidney(s) is probably better than no transplantation. Transplantation teams should continue to focus on the development of age-specific strategies for promotion of long-term successful outcomes, as well as the identification of sufficient resources to provide them.
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